Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 15,186 | 13,374 | 14,076 | 11,965 | 12,266 |
| Cost of Goods | 1,304 | 1,214 | 1,012 | 1,073 | 1,155 |
| Gross Profit | 13,882 | 12,160 | 13,064 | 10,892 | 11,111 |
| Operating Expenses | 34,756 | 34,923 | 32,437 | 32,509 | 31,182 |
| Operating Income | -20,570 | -22,549 | -19,361 | -21,544 | -19,916 |
| Interest Expense | 1,991 | 1,768 | 1,846 | 1,797 | 1,696 |
| Other Income | 1,879 | -6,001 | 5,665 | -847 | 2,846 |
| Pre-tax Income | -20,682 | -30,318 | -15,542 | -24,188 | -18,766 |
| Net Income Continuous | -20,682 | -30,318 | -15,542 | -24,188 | -18,766 |
| Net Income | $-20,682 | $-30,318 | $-15,542 | $-24,188 | $-18,766 |
| EPS Basic Total Ops | -0.26 | -0.39 | -0.21 | -0.31 | -0.24 |
| EPS Basic Continuous Ops | -0.27 | -0.39 | -0.20 | -0.31 | -0.24 |
| EPS Diluted Total Ops | -0.26 | -0.39 | -0.19 | -0.31 | -0.25 |
| EPS Diluted Continuous Ops | -0.27 | -0.39 | -0.17 | -0.31 | -0.23 |
| EBITDA(a) | $-19,918 | $-22,066 | $-18,870 | $-21,035 | $-19,364 |